{
    "Trade/Device Name(s)": [
        "MAS\u00ae Omni-CORE",
        "Thermo Scientific MAS\u00ae Omni-CORE",
        "MAS\u00ae OmniCORE"
    ],
    "Submitter Information": "Microgenics Corporation",
    "510(k) Number": "K110738",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092051",
        "K960824"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "September 15, 2011",
    "Summary Letter Received Date": "September 20, 2011",
    "Submission Date": "October 31, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Acetaminophen",
        "Albumin",
        "Alkaline Phosphatase",
        "Alpha-1-Acid Glycoprotein",
        "Alpha-1-Antitrypsin",
        "Alpha-2-Macroglobulin",
        "ALT",
        "Amikacin",
        "Amylase",
        "AST",
        "Bile Acids",
        "BUN",
        "Caffeine",
        "Calcium",
        "Chloride",
        "Cholesterol",
        "CK",
        "CO2",
        "Copper",
        "Cortisol",
        "Creatinine",
        "Digoxin",
        "Disopyramide",
        "Ethanol",
        "Ethosuximide",
        "Ferritin",
        "Gentamicin",
        "GGT",
        "Glucose",
        "Haptoglobin",
        "IgA",
        "IgE",
        "IgG",
        "IgM",
        "Iron",
        "LDH",
        "Lipase",
        "Lithium",
        "NAPA",
        "Sodium",
        "Zinc",
        "Antistreptolysin O (ASO)",
        "Apolipoprotein A1",
        "Apolipoprotein B",
        "Beta 2 Microglobulin",
        "Bilirubin, Direct",
        "Bilirubin, Total",
        "C3 Complement",
        "C4 Complement",
        "Carbamazepine",
        "Ceruloplasmin",
        "C-Reactive Protein (CRP)",
        "HDL Cholesterol",
        "Iron Binding Capacity, Total (TIBC)",
        "Lactic Acid",
        "LDL-Cholesterol",
        "Lidocaine",
        "Lipoprotein (a)",
        "Magnesium",
        "Methotrexate",
        "Osmolality",
        "Phenobarbital",
        "Phenytoin",
        "Phosphorus",
        "Potassium",
        "Prealbumin",
        "Primidone",
        "Procainamide",
        "Pseudocholinesterase (PCHE)",
        "Quinidine",
        "Rheumatoid Factor (RF)",
        "Salicylate",
        "Thyroxine, Total T4",
        "Theophylline",
        "Thyroid Stimulating Hormone, TSH",
        "Tobramycin",
        "Total Protein",
        "Transferrin",
        "Triglycerides",
        "Tricyclic Antidepressants (TCA)",
        "T-Uptake",
        "Unsaturated Iron Binding Capacity (UIBC)",
        "Uric Acid",
        "Valproic Acid",
        "Vancomycin",
        "Lipoprotein (LpA)",
        "N-Acetylprocainamide",
        "Thiiodothyronine, Total T3",
        "Thiiodothyronine Free T3",
        "Human Chorionic Gonadotrophin (hCG)",
        "Glutamate Dehydrogenase (GLDH)",
        "Hydroxybutyrate Dehydrogenase (HBDH)",
        "Kappa Light Chain",
        "Lambda Light Chain",
        "Properidin Factor B"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Assayed control material"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for MAS\u00ae Omni-CORE assayed control material for monitoring assay conditions in clinical chemistry determinations.",
    "Indications for Use Summary": "Intended for use as an assayed control for monitoring assay conditions in many clinical laboratory determinations; to be included with patient serum specimens for assaying various constituents with specified systems.",
    "fda_folder": "Clinical Chemistry"
}